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Background: Preimplantation bovine development is emerging as an attractive experimental model, yet little is
known about the mechanisms underlying trophoblast (TE)/inner cell mass (ICM) segregation in cattle. To gain an
insight into these processes we have studied protein and mRNA distribution during the crucial stages of bovine
development. Protein distribution of lineage specific markers OCT4, NANOG, CDX2 were analysed in 5-cell, 8–16
cell, morula and blastocyst stage embryos. ICM/TE mRNA levels were compared in hatched blastocysts and
included: OCT4, NANOG, FN-1, KLF4, c-MYC, REX1, CDX2, KRT-18 and GATA6.
Results: At the mRNA level the observed distribution patterns agree with the mouse model. CDX2 and OCT4
proteins were first detected in 5-cell stage embryos. NANOG appeared at the morula stage and was located in the
cytoplasm forming characteristic rings around the nuclei. Changes in sub-cellular localisation of OCT4, NANOG and
CDX2 were noted from the 8–16 cell onwards. CDX2 initially co-localised with OCT4, but at the blastocyst stage a
clear lineage segregation could be observed. Interestingly, we have observed in a small proportion of embryos (2%)
that CDX2 immunolabelling overlapped with mitotic chromosomes.
Conclusions: Cell fate specification in cattle become evident earlier than presently anticipated – around the time
of bovine embryonic genome activation. There is an intriguing possibility that for proper lineage determination
certain transcription factors (such as CDX2) may need to occupy specific regions of chromatin prior to its activation
in the interphase nucleus. Our observation suggests a possible role of CDX2 in the process of epigenetic regulation
of embryonic cell fate.
Keywords: Bovine blastocyst, ICM/TE lineage segregation, Cell fate, Gene expression patterns, CDX2, Mitotic retentionBackground
Despite recent advances in developmental biology our
understanding of cell fate decisions during preimplantation
development of non-rodent mammals still remains limited.
With growing prospects of the use of stem cell research in
medicine and animal biotechnology, cell lineage formation
in species of economic significance, such as cattle or sheep
is of increasing interest. Sharing many similarities with
human embryos, bovine embryos present an attractive
model for investigating the fundamental mechanisms of* Correspondence: zofia.madeja@jay.up.poznan.pl
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reproduction in any medium, provided the orearly development. These include the timing of epigenetic
reprogramming, the stage of the embryonic genome
activation and the timing of development [1,2].
During the initial stages of mammalian development two
successive differentiation events lead to the segregation of
the three committed cell lineages. The first event begins at
the compacted morula stage, where the outer layer of cells
segregates to become the epithelial trophectoderm (TE)
that gives rise to the embryonic part of the placenta. The
inner layer of cells (inner cell mass, ICM) will produce
the embryonic lineages. The second round of segregation
divides the ICM into primitive ectoderm, which gives rise
to the epiblast (nascent embryo proper) and the primitive
endoderm (PrE) that forms the extra-embryonic endodermLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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endoderm. The first cell fate decisions are governed by
a combination of interactions between transcriptional
networks, signalling, cell polarity and cell position within
the morula [3]. At the cellular level the ICM/TE segregation
is initiated by two rounds of differentiative divisions that re-
sult in spatially and molecularly distinct cell populations.
The differentiation of TE may be regarded as the hallmark
event in mammalian preimplantation development, as it
is the first tissue that becomes differentiated during em-
bryogenesis. Due to its biological function the ICM needs
to retain its pluripotency status much longer, since the
establishment of the three germ layers (endoderm, meso-
derm, ectoderm) occurs soon after implantation in rodents
and around day 14 in cattle [4]. In mice the process of
TE formation initiates at the 8-cell stage, when embryos
undergo compaction manifested by an increased intra-
cellular adhesion, blastomere flattening and formation
of adherens junctions [5]. Concurrent with this event,
cells acquire an apical domain rich in proteins, such as the
atypical protein kinase aPKC [6], the polarity protein Par3
[7] and the apical protein Erizn [8]. During the subsequent
cell divisions (from 8–16 and from 16–32 cell stage) the
differential inheritance of the apical, polarised surface
determines either the TE or the ICM fate [9,10].
At the molecular level the initiation of the TE lineage
formation is promoted by the action of Tead4, which was
shown to regulate multiple transcription factors important
for trophoblast development [11,12]. Trophoblast mainten-
ance depends on consecutive activation of factors such as
caudal-type homeodomain transcription factor 2 (Cdx2),
trans-acting GATA binding transcription factor (Gata3),
eomesodermin (Eomes) and epithelial-specific ETS factor
(Elf5) ([13-18], rev. [19]). Cdx2 is the earliest known
marker used to distinguish between mouse TE and ICM.
Its expression begins at the 8-cell stage and becomes
restricted to the outside cells at the time of blastocyst
formation [15,20]. The polarity of the outer blastomeres is
possibly the main factor responsible for up-regulation of
Cdx2 expression in these cells [21]. Once Cdx2 expression
becomes restricted to the outer cells, factors related to
the maintenance of pluripotency and the ICM lineage
formation are repressed. This action is maintained
through a feedback loop regulated by Elf5 via the mutual
suppression between Cdx2 and octamer binding transcrip-
tion factor 3/4 (Oct3/4) and homeobox transcription factor
(Nanog) complexes. Functional studies showed that Cdx2
blocks Oct3/4 activity in the TE committed cells, as in the
presence of Cdx2, Oct3/4 occupied the heterochromatic
regions of the nuclei [22]. More importantly, it was shown
that Cdx2 can post-transcriptionally inactivate Oct4, thus
TE commitment may occur before Oct4 transcription is
terminated [22,23]. The establishment of the ICM and the
epiblast relies on the interactions of transcription factorsOct4, Nanog, Sall4 and Sox2 ([24-27], rev. [28]). These
factors are also key players in maintaining embryonic
stem cell (ESC) pluripotency and possess an ability to
auto-regulate their own transcription by sustaining a self-
reinforcing transcriptional network. Sox2 can synergistically
act with Oct3/4 to activate Oct-Sox enhancers, which in
turn regulate the expression of pluripotent stem cell
specific genes such as Nanog, Oct3/4 and Sox2 [29]. In-
activation of Nanog results in peri-implantation lethality
as mouse blastocysts fail to form the epiblast. Moreover,
Nanog-null embryos exhibit a PrE marker Gata6 through-
out the ICM [25,30] and knockdown of Nanog gene in
mouse blastocysts and ESC resulted in an up-regulation of
the TE specific genes (Cdx2 and Hand1) [31].
The unique molecular interactions underlying the ICM/
TE lineage specification in cow and other ungulate species
still remains to be described in detail. The work by Berg
et al. [32] shows that OCT4 expression in cattle TE may
be retained until the PrE/epiblast segregation, indicating
that the trophoblast cells may not become committed
during bovine pre-implantation development at stages
developmentally equivalent to the mouse. It was shown
that at the early stages, CDX2 does not repress OCT4
expression, as the bovine OCT4 locus does not contain the
cis-acting regulatory region necessary for extinguishing its
transcription in TE [32]. Moreover, it was indicated that
the TE cells of an early bovine blastocyst (7dpi) retain the
ability to contribute to the ICM derivatives in chimeras
[32]. It is therefore plausible that the standard ICM/TE
markers described in the mouse become segregated at
different (or later) stages during the ruminant embryo
development.
Using cattle as a non-rodent model animal we have
aimed to describe the mutual spatial allocation of factors
that have been shown to be important for lineage commit-
ment in the mouse. We have followed the specific distribu-
tion patterns from the very early stages of development,
through the time of embryonic genome activation (EGA),
until the hatched blastocyst (HBl) stage. Contrary to what
is claimed by the majority of published reports, we suggest
that cell fate decisions in cattle may become initiated
earlier than it is presently anticipated – around the time
of embryonic genome activation. Of most interest our
study indicates that CDX2 could possibly be subject to the
phenomenon of mitotic retention, which may imply a role
in epigenetic regulation of embryonic cell fate.Methods
In vitro production of bovine embryos (IVP)
All procedures were performed in accordance with the
guidelines of the National Ethical Commission for Animal
Research (Ministry of Science and Higher Education,
Poland). The study was approved by the Local Ethical
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Unless stated otherwise, all reagents used for IVP culture
media preparation were supplied by Sigma-Aldrich, Poland.
The media were made based on sterile embryo-tested
water (Gibco, Life Technologies Poland).
Bovine cumulus-oocyte-complexes (COC) were collected
from slaughterhouse ovaries. COCs were aspirated from
2–6 mm follicles, underwent a restrictive selection process
[33] and were subjected to in vitro maturation (IVM).
COCs were matured for 24 hours in TCM-199 medium
containing 1 mg/ml fatty acid free BSA (fafBSA), 0.05 mg/
ml gentamycin, 0.022 mg/ml Na-pyruvate, 2.2 mg/ml
NaHCO3 and hormones (5 UI/ml hCG, 10 UI/ml PMSG,
Intervet) at 39°C in humidified atmosphere with 5% CO2
(as described by Stinshoff et al. [34]). Insemination was
done with bull sperm supplied by the Centre for Animal
Breeding and Reproduction (Poznan, branch Tulce; 63–004
Tulce, Poland) at a concentration of 1 × 106/ml. The sperm
were washed twice by centrifugation and re-suspended
in standard IVF-Sperm-Talp medium supplemented with
4 mg/ml fafBSA [35]. PHE (penicillin, hypotaurine, epi-
nephrine) was used for sperm capacitation. After 20 hours
of gamete co-incubation at 39°C in humidified atmosphere
with 5% CO2, the cumulus cells were mechanically re-
moved by pipetting. The presumptive zygotes were trans-
ferred in groups of 10 to 30 μl culture drops covered by
embryo culture tested mineral oil. In vitro embryo culture
(IVC) was carried out at 39°C in humidified atmosphere
of 5% CO2, 5% O2, 90% N2 in a modular chamber placed
inside an incubator. The IVC medium consisted of synthetic
oviduct fluid culture medium (SOF) supplemented with
essential and non-essential amino acids (MEM, BME)
and 4 mg/ml fafBSA, as described by Holm et al. [36]. At
3dpi the embryos were subjected to selection. Only cleaved
embryos were placed in fresh IVC medium and were left
in culture until they had reached the developmental stage
required for the experiments.Embryo collection for qualitative and quantitative
PCR analysis
The selected material was washed with 0.25% polyviny-
lpirrolidone (PVP) in PBS placed in 1.5 ml tubes in min-
imal volume, frozen in liquid nitrogen and stored in −80°C.
Qualitative gene expression analyses were performed
on bovine embryos at 8–16 cell stage, morula stage and
hatched blastocysts (9dpi). 8–16 cell embryo samples
were collected in pools, each consisting of 20 embryos.
Morulae were collected in groups of 12 and 3 un-dissected
blastocysts were pooled to make up one sample. We have
collected 6 independent samples for each stage, collected
over several IVP experiments. This allowed to eliminate
the possible bias in gene expression analyses which coulddistort the results if all samples were collected during one
IVP experiment.
Quantitative gene expression analysis were performed
on hatched blastocysts 9dpi. In order to reveal the possible
differences in gene expression levels between the ICM and
the TE, the blastocysts were microsurgically dissected.
The ICMs made up one sample and the corresponding
TEs made up the other sample. The ICM/TE samples
were pooled in groups of 3 as we have empirically
established that it was the lowest material content that
allowed for efficient RNA extraction, cDNA synthesis and
reliable real-time PCR analysis. In total we have collected
24 independent samples (12 ICM and 12 TE) from 72
embryos. For the means of quantitative calculations we
have also collected 6 samples each containing 3 whole
(un-dissected) HBls, that served as calibrators for the
purpose of transcript quantification.
RNA extraction and cDNA synthesis
Total RNA was extracted from embryos using the High
Pure miRNA Isolation Kit (Roche Diagnostics, Poland)
according to the manufacturer’s protocol. This kit was
developed for the extraction of small RNA molecules,
and it has proven to be an effective tool in extracting
RNA from small copy number samples such as the pre-
implantation embryos. RNA concentration was mea-
sured on NanoDrop (Thermo Scientific, USA). For each
sample reverse transcription was performed from 100 ng
of total RNA. cDNA synthesis was carried out with the
Transcriptor High Fidelity cDNA Synthesis Kit (Roche
Diagnostics) according to the manufacturer’s protocol.
The samples were stored in −20°C.
Quantitative real-time RT-PCR analysis
In short, we have compared the expression level of a certain
gene in ICM and TE and related it to an un-dissected
embryo. The experiments were performed on Roche Light
Cycler 2.0 instrument. The calculations were based on
relative gene expression data analyses using real-time
PCR and the 2-ΔΔCT method as described by Livak and
Schmittgen [37] and Schmittgen and Livak [38]. In order
to establish the differences in gene expression levels
between the ICM and the TE, the samples containing
whole blastocysts served as reference points for relative
gene expression level calculations. HBL was referred to as
a calibrator. Gene expression levels were normalised to
the expression level of the 18S rRNA gene that served as a
reference. Each sample was subjected to gene expression
analyses with all of the primer sets designed for the panel
of chosen lineage specific genes and for the reference
gene. All reactions were repeated in triplicates. The primers
were designed to span the two neighbouring exons
(Table 1). The reactions were carried out in 10 μl capillaries
(Roche Diagnostics) and the PCR mix comprised of 1 μl
Table 1 Primer pairs and annealing conditions used for the real-time PCR gene expression analyses
Name Sense primer Antisense primer Product size Annealing temperature
CDX2 CTTTCCTCCGGATGGTGATA AGCCAAGTGAAAACCAGGAC 113 bp 58°C
c-MYC TGGACGCTAGATTTCCTTCG GCTGCTGCTGGTGGTAGAAG 155 bp 58°C
FN1 GCACTATGGCCAAAGAGAGG AACAGGAGACAAGGGTGTGG 109 bp 58°C
KLF4 AAACCAAAGAGGGGAAGACG ATGTGTAAGGCGAGGTGGTC 291 bp 58°C
KRT18 GAGATCGAGGCTCTCAAGGA GTCCAGCTCCTCTCGGTTCT 201 bp 58°C
NANOG AAACAACTGGCCGAGGAATA AGGAGTGGTTGCTCCAAGAC 194 bp 58°C
OCT4 GTTTTGAGGCTTTGCAGCTC CTCCAGGTTGCCTCTCACTC 185 bp 58°C
GATA6 CTGCGGTCTCTACAGCAAGA GTGGTCGTGGTGTGACAGTT 117 bp 58°C
REX1 GGAAGAGGACCCACTCCTTC ACTTGGCCTCCTAGTGCATC 241 bp 58°C
18S rRNA GGAGAGGGAGCCTGAGAAAC TCGCGGAA GGATTTAAAGTG 170 bp 58°C
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(Roche Diagnostics), 5 mM MgCl2 (Roche Diagnostics),
0.3 μM of primers and 1 μl of cDNA. Real-time PCR reac-
tion conditions included: initial polymerase activation at
95°C for 10 min, followed by 42 cycles of denaturation at
95°C for 10 s, annealing (primer specific, listed in Table 1)
for 10 s, elongation at 72°C for 20 s. Product specificity was
confirmed by melting analysis.
Statistical analysis
A certain level of heterogeneity was noted within the
analysed sample groups, thus the data did not follow
normal distribution. Therefore to analyse statistically
significant variability in gene expression levels between
ICM and TE, the Wilcoxon signed-rank test was applied.
Due to the nature of the experiment (number of repeats
of each individual sample within one group – ICM/TE) the
data was processed as median and presented as ± SEM.
Differences of P < 0.05 were considered significant. The
mRNA data expression was analysed using the statistical
package SPSS 17.0.
Whole mount immunofluorescence
The material included embryos at stages crucial for bovine
development: 5-cell, 8-16-cell (bovine embryonic genome
activation), morula (compaction) and blastocysts at various
developmental stages - early blastocyst (7dpi), expanding
blastocyst (8dpi) and hatched blastocyst (9dpi) as classified
by Rekik et al. [39]. The embryos were selected during
the same IVP experiments as the material collected for
qualitative and quantitative gene expression analyses
(Table 2).
From embryos of developmental stages earlier than HBL,
zona pellucida (ZP) was removed prior to fixation by a
brief incubation in acid Tyrode’s solution supplemented
with 0.1 N HCl. The embryos were processed as follows:
briefly washed in PBS (pH 7.3) and fixed with 4% parafor-
maldehyde in PBS with 0.1% Triton X-100 and 0.1%Tween20 (pH 8.0) for 15 min at 39°C (Sigma Aldrich).
Immunofluorescent protein labeling was carried out as
previously described by Madeja et al. [40] and Plusa et al.
[41] with some modifications: permeabilisation with 0.55%
Triton X-100/PBS for 20 min; blocking of non-specific
antibody binding with 10% fetal calf serum in PBS, 60 min
at room temperature (RT); three washes in 0.1% Triton
X-100/PBS (PTX); overnight incubation with primary
antibodies (ABI) diluted 1:50 in blocking buffer at 4°C;
three washes in PTX; blocking for 40 min at RT; secondary
antibody (ABII) incubation at 1:200 dilution; three washes
in PTX; embryo mounting on concave glass slides in 40 μl
drop containing antifade solution with DAPI (Vectashield
mounting medium, Vector Laboratories, USA). The slides
were stored at +4°C.
To avoid cross-reactivity between the AB hosts the
embryos were double labeled with various sets of ABI and
ABII. The primary antibody set included: anti-CDX2 -
mouse monoclonal AB (Abcam, UK, ab15258) or rabbit
polyclonal AB (Abcam, ab88129); anti-OCT4 rabbit
polyclonal AB (Abcam, ab18976) or goat polyclonal AB
(Abcam, ab27985); anti-NANOG rabbit polyclonal AB
(PeproTech, UK, 500-P236), anti-trimethyl-histone H3
(Lys9) AB (Merck-Millipore, 07–442). The secondary
antibody set consisted of Santa Cruz Biotechnology, USA,
ABII: donkey anti-goat Rhodamine conjugated AB (sc-
2094) or donkey anti-goat FITC conjugated AB (sc-2024),
donkey anti-mouse Rhodamine conjugated AB (sc-2300);
donkey anti-rabbit FITC conjugated (sc-2090), chicken
anti-rabbit Rhodamine conjugated AB (sc-2862), chicken
anti-mouse FITC conjugated AB (sc-2989); goat anti-
mouse Rhodamine conjugated AB (sc-2092), goat anti-
mouse FITC conjugated AB (sc-2010), goat anti-rabbit
Rhodamine conjugated AB (sc-2091), goat anti-rabbit,
FITC conjugated (sc-2012). Blocking peptide for CDX2:
Abcam (ab99158). Fluorescent signals were visualized
using a Zeiss Axiovert 200 M laser scanning confocal
microscope.
Table 2 Experimental groups and antibody set-up for single and double immunolabelling
Developmental 5-cell (n) 8-16 cell (n) Morula (n) Blastocyst Blastocyst Hatched
Stage 7dpi (n) 8/9dpi (n) Blastocyst
9dpi (n)
Number of immunostained embryos
per staining set-up (n)
1 (5) 1 (5)
1 (4) 2 (4) 2 (5)
1 (10) 1 (5) 2 (4) 3 (4) 3 (6)
2 (10) 2 (4) 3 (4) 4 (4) 4 (5)
3 (10) 3 (4) 4 (4) 5 (4) 6 (5) 5 (6)
4 (10) 4 (4) 6 (6) 6 (9) 7 (5) 6 (12)
5 (10) 5 (5) 8 (4) 7 (8) 10 (10) 7 (11)
9 (20) 9 (11) 8 (6) 8 (13)
10 (5) 9 (4) 9 (10)
10 (8) 10 (12)
Antibody staining set-up 1 – CDX 2 (ab15258) mouse 6 – CDX 2 (ab15258) mouse + OCT4 (ab18976) rabbit
2 – CDX 2 (ab88129) rabbit 7 – CDX 2 (ab88129) rabbit + OCT4 (ab27985) goat
3 – OCT4 (ab27985) goat 8 – CDX 2 (ab15258) mouse + NANOG (500-P236) rabbit
4 – OCT4 (ab18976) rabbit 9 – CDX 2 (ab15258) mouse + H3K9me3 (07–442) rabbit
5 – NANOG (500-P236) rabbit 10 – OCT4 (ab27985) goat + NANOG (500-P236) rabbit
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Gene expression patterns of key lineage specific marker
genes during bovine preimplantation development
In order to follow lineage specification during bovine
preimplantation development we have first analysed the
mRNA expression profile of selected pluripotency and
lineage specific markers: OCT4, NANOG, FN-1, KLF4,
c-MYC, REX1, which are important for maintaining
pluripotency in mouse and human and CDX2, KRT-18
which are crucial for the establishment and the main-
tenance of TE as well as GATA6 involved in mouse PrE
lineage segregation. Initially we have performed qualitative
gene expression analyses to establish which genes were
present in cattle morula and blastocyst stage embryos.
Transcripts for all of the mentioned genes were detected
in blastocysts and all except c-MYC and GATA6 were
present in the morula stage embryos (Figure 1). Because for
protein immunolocalisation we have chosen to concentrate
on the 3 canonical lineage markers OCT4, NANOG and
CDX2, we have also checked the presence of gene specificFigure 1 Qualitative gene expression profiles of lineage markers in bmRNAs in 8–16 cell stage embryos, which in bovine is the
time of major embryonic genome activation (Figure 1).
The expression patterns of key lineage specific marker
genes in bovine blastocysts 9dpi resembles the classical
mouse model
In order to establish whether the investigated transcription
factors were differentially expressed between bovine ICM
and TE we have concentrated on the latest developmental
stage that may be obtained in vitro under standard culture
conditions – the hatched blastocyst stage (HBl, 9dpi).
To separate the ICM from the TE, the embryos were
microsurgically dissected. This method allowed collection
of comparable samples as, unlike in rodents and higher
primates, the bovine ICM is a clearly pronounced struc-
ture where polar TE quickly disappears after blastocyst
expansion [42].
The results revealed significantly higher expression levels
of OCT4, NANOG and FN-1 in bovine ICM as compared
to TE (Figure 2). OCT4 mRNA level showed a 4-foldovine 8–16, morula and HBl stage embryos.
Figure 2 Comparison of gene expression levels between bovine ICM and TE. The graph represents relative expression levels of pluripotency
and lineage specific genes in bovine ICM and TE. Asterisks denote significant differences in mRNA levels: * P < 0.05; ** P < 0.01. Error bars
represent SEM.
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FN-1 gene expression levels were 6-fold (P = 0.002) and
4-fold (P = 0.015) higher in the ICM respectively. Out
of 12 TE samples 6 did not express NANOG. The per-
sistent expression of NANOG was possibly related to
slight differences in the developmental timing of some of
the blastocysts, as bovine blastocyst hatching is variable
and takes place between 7.5dpi and 11dpi [43,44]. In par-
allel, trophoblast related factors CDX2 and KRT-18 also
displayed lineage specific mRNA distribution pattern. In 9
out of 12 ICM samples CDX2 transcripts were not detected.
Overall CDX2 expression level was 3-fold higher in bovine
trophoblast versus the ICM. However the difference was
not statistically significant (P = 0.071). The expression
levels of KLF4, c-MYC and REX1 showed no specific dif-
ferences between the ICM and the TE. GATA6 expression
profile pointed towards its higher abundance in the ICM
(2-fold), however a notable level of variability between
the samples was observed (SEM = 6.33).ICM specific transcription factors exhibit dynamic
changes in subcellular localisation during bovine
development
To complement the observations made from studies of
ICM and TE transcription profiles we have immunolabelled
the classical lineage and pluripotency marker proteins
during bovine preimplantation period from the 5-cell
stage until the hatched blastocyst stage (9dpi). Embryos
were double labelled for various combinations of proteins:
OCT4, NANOG and CDX2, which allowed examination
of their mutual spatial correlation (Table 2). The control
groups underwent the same staining protocol as the
experimental group, with the exception of the primary
antibody (the results are provided in the Additional file 1:
Figure S1 section). The specificity of the CDX2 primary
AB binding was verified with the use of blocking peptide
(Figure 3). OCT4 binding was validated by performing
double immunolabelling with both of the anti OCT4 anti-
bodies used (Figure 4). The application of anti NANOG
Figure 3 CDX2 immunolabelling controls. The binding specificity of the rabbit polyclonal anti CDX2 primary antibody (ab88129) (a) and
mouse monoclonal anti CDX2 primary antibody (ab15258) (b) was verified with the use of blocking peptide (ab99158) prior to the antibody
staining. The secondary antibodies used were goat anti-rabbit Rhodamine conjugated (sc-2091) in (a) and goat anti-mouse Rhodamine
conjugated (sc-2092) in (b). Dashed circle marks the metaphase plate. DAPI labels chromatin.
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proven by Puy et al. [45] and He et al. [46].
Inner cell mass lineage allocation
OCT4 and NANOG protein distribution patterns were
investigated during the crucial stages of bovine preim-
plantation development. NANOG was not detected in 5-
cell and 8–16 cell stage embryos, however as revealed by
qualitative gene expression analysis, transcripts for both
of these proteins were present (Figure 1). OCT4, the key
transcription factor necessary to maintain the ICM, at the
5-cell stage occupied the apical surface of the blastomeres
(a pattern identified in all of the analysed embryos).
Around the 8-cell stage, the protein could be for thefirst time in development, located in the nuclei of all
cells (Figure 5a). The situation changed at the morula
stage, where both OCT4 and NANOG could be detected,
however the distribution patterns were different. NANOG
was localised in the cytoplasm of some cells, forming char-
acteristic rings around the nucleus (Figure 5b, arrowheads).
This data, combined with mRNA detection, suggests that
NANOG protein appeared de novo at the morula stage as
a product of the embryonic genome. Moreover NANOG
positive cells seemed to be located in one area of the
embryo (possibly the nascent ICM). At the same develop-
mental stage OCT4 produced a nuclear signal in all cells.
In early blastocysts (7dpi) OCT4 and NANOG proteins
were found to be located both in the ICM and in the
Figure 4 OCT4 immunolabelling controls. Control immunostaining with both of the anti OCT4 antibodies used in the experiment. (a1)
presents HBL single labelled for OCT4 with goat polyclonal primary antibody (ab27985) detected with mouse anti-goat Rhodamine conjugated
secondary antibody (sc-24900). (a2) presents single labelled HBl with rabbit polyclonal anti OCT4 antibody (ab18976) detected with goat
anti-rabbit FITC conjugated secondary antibody (sc-2012). (b) indicates colocalisation of the OCT4 in HBl double-labelled with both of the anti
OCT4 antibodies. The secondary antibodies used were mouse anti-goat Rhodamine conjugated (sc-2490) and donkey anti-rabbit FITC conjugated
(sc-2090). DAPI labels chromatin.
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were different. In the ICM cells both NANOG and OCT4
displayed a nuclear localisation, however NANOG occupied
the whole territory of the nucleus, whereas OCT4 showed
more peripheral localisation, with “rings” at the nuclear
periphery of the ICM cells (Figure 6a). In trophoblast cells,
where OCT4/NANOG activity is redundant, proteins
remained in the cytoplasm (Figure 6a, arrows). At 7/8dpi
OCT4 positive blastomeres predominantly located in the
ICM, however some positive signal was still detected
within the TE cell population (Figure 6b). At the time of
blastocyst hatching, still some residual immunolabelling
could be observed in the TE layer, as indicated by a single
cell co-expressing NANOG and OCT4 in Figure 6c.
Following OCT4/CDX2 distribution patterns at the stages
of blastocyst formation we have concluded that the
process of ICM specific OCT4 allocation is gradual.
Concomitant with blastocyst expansion at 8dpi OCT4
expressing cells become limited to the ICM, however
single positive cells could be still identified in the TE of
about 50% of the analysed embryos. After blastocyst
hatching we have noted further evidence for lineage
segregation. Both OCT4 and NANOG became exclusively
ICM specific (Figure 6d). Within the group of cells
expressing OCT4 and NANOG, we have identified cells
expressing only NANOG (as indicated by red arrowheads
in Figure 7b) and cells expressing both factors, with
NANOG signal being predominantly nuclear and OCT4showing some nuclear, some cytoplasmic localisation
(white arrowheads in Figure 7b).
Trophoblast specific factor CDX2 changes its sub-nuclear
localisation during bovine preimplantation development
To follow the process of bovine TE lineage specification,
we have examined CDX2 distribution profile in 5-cell,
8–16 cell, morula and blastocyst stage embryos (7-9dpi).
In 5-cell embryos CDX2 was located in the cytoplasm of
all cells (Figure 8a) and unlike OCT4 showing a more
pronounced distribution within the blastomeres and
absence from the nucleus. At the subsequent stages of
development CDX2 specifically allocated to the embryonic
cell nuclei (Figure 8a). TE lineage specification becomes
evident at more advanced developmental stages. At 7/8
dpi CDX2 segregation to the trophoblast cells could
already be noted, however some signal was still detected
within the ICM cells (Figure 8b) as indicated by a confocal
section through an early blastocyst presented in Figure 6b.
A detailed analysis of the confocal images of the morula
stage embryos indicated that the distribution pattern within
the nucleus was not uniform. CDX2 formed a clear rim
around the nuclear periphery and distinctive regions of
high signal intensity were identified in both 8–16 cell and
morula stage embryos (Figure 9a,b). These regions in
some areas overlapped with DAPI (the fluorochrome used
for DNA labelling: -4,6- diamidino-2-phenylindole). It was
observed that DAPI preferably binds to the AT-rich regions
Figure 5 Distribution of OCT4 and NANOG in the early stages of bovine development. Immunofluorescent detection of OCT4 (a) and
NANOG (b) followed through the early stages of bovine development. In 5-cell embryos OCT4 (a) localised at the apical surface of the
blastomeres, and from the 8–16 cell stage weak signal was detected in cell nuclei and mostly absent in the cytoplasm. NANOG (b)
immunostaining was for the first time detected at the morula stage exhibiting a specific cytoplasmic localisation with characteristic rings around
the nuclear periphery (indicated by arrow heads). From the early stages of blastocyst formation OCT4 and NANOG signals were detected in the
nuclei of the ICM cells. Confocal sections were taken every 3 μm. Chromatin was labelled with DAPI.
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that labelling property we have used an antibody directed
against histone H3 lysine 9 tri-methylation (H3K9me3),
which is highly correlated with predominantly transcrip-
tionally silent constitutive heterochromatin regions. The
results of double immunofluorescent staining revealed
CDX2 and H3K9me3 colocalisation in the interphase nuclei
of some cells. Most interestingly in double labelled 8-cell
bovine embryos (4 out of 20) we have observed CDX2
localisation at specific regions of the metaphase chromo-
somes which colocalised with the H3K9me3 (Figure 9a).
Also in 4 out of 9 metaphase plates that were altogether
detected in 11 morula stage embryos, the specific chromo-
some coating was also visible (Figure 9b). On close examin-
ation we were also able to detect a CDX2 positive signal in
a region occupied by a metaphase plate in a single TE cell
of late blastocyst (Figure 9c). At this point we would like to
stress that data interpretation must be done with much
caution and that the possible CDX2 coating of metaphase
chromosomes is presented as an observation.Discussion
The existing evidence unequivocally indicates species spe-
cific differences in cell lineage allocation, as was highlighted
by Janet Rossant: “A mouse is not a cow” [48]. However, in
light of growing understanding of the signalling processes
that control pre-implantation development, we believe
that it is more important to ask whether we can identify
the same/similar molecular mechanisms that govern cell
fate decisions in mouse and in early bovine embryos. To
address this question one has to be aware of the species
specific differences in early development. The period of
mouse preimplantation development is very short and
takes 3.5 to 4.0 days. Bovine (and porcine) pre-attachment
development is extended in time, as between the blasto-
cyst formation and implantation there is about a 10-day
time window during which the embryo undergoes further
differentiation. Thus, it may be expected that the events
leading to cellular specification and lineage formation in
cattle may not be as rapid as in mice. Until now, with
some exceptions the authors have concentrated mainly
Figure 6 ICM lineage segregation during bovine blastocyst formation. (a) presents a single optical section through an ICM of bovine early
blastocyst (7dpi) immunostained for NANOG and OCT4. The boxed areas are enlarged in the bottom row. NANOG shows nuclear and OCT4
sub-nuclear localisation in ICM White arrows indicate cytoplasmic localisation of NANOG and OCT4 in the trophoblast cells in the vicinity of the
ICM. Confocal sections were taken every 2 μm (b) shows a 3-D reconstruction of confocal images of an early blastocyst (7/8dpi) double labelled
for CDX2 and OCT4. OCT4 was predominantly located in the ICM, but some signal was detected in the TE cells. Dashed circle marks the ICM.
(c) is a 3-D compilation of optical sections taken through hatching blastocyst (8/9dpi) labelled for NANOG and OCT4. Dashed circle marks the
ICM. (d) shows a 3-D reconstruction composed of 30 confocal sections (taken every 3 μm) through bovine hatched blastocyst (9dpi) double
labelled for CDX2 and OCT4. At this stage OCT4 positive cells entirely segregate to the ICM. CDX2 becomes restricted to the trophoblast. DAPI
marks chromatin. Confocal sections were taken every 3 μm.
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Figure 7 OCT4 and NANOG distribution pattern in bovine hatched blastocysts (9dpi). The top panel (a) of images shows a 3-D reconstruction of
confocal sections taken through bovine HBL. Dashed line encircles the ICM. The bottom panel (b) represents a single optical section through the ICM of
the same embryo. OCT4 and NANOG localise in the ICM, but a certain degree of signal segregation was observed. Cells indicated with red arrowheads
express NANOG and cells indicated with white arrowheads co-express both proteins. DAPI marks chromatin. Confocal sections were taken every 3 μm.
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Three publications compared transcript abundance between
bovine ICM and TE [49-51] however, the approach was
mainly qualitative and did not include crucial develop-
mental stages prior to blastocyst formation. Moreover,Figure 8 Distribution of CDX2 during the early stages of bovine deve
distribution from the 5-cell stage. Initially CDX2 was located in the cytoplas
specifically allocated to the embryonic cell nuclei and became TE specific a
early stage blastocyst (7/8dpi) already presented in Figure 5a. At this stage
staining still visible in the ICM (highlighted by the dashed circle). DAPI marthe existing data is often inconclusive as some authors
showed no difference in OCT4 and NANOG protein dis-
tribution in bovine ICM and TE [52,53], whereas other
[54,55] showed partial OCT4 and NANOG expression
in both embryonic lineages. On a contrary Kuijk et al.lopment. (a) presents the specific changes in the CDX2 protein
m of all cells and was absent in the nuclei. From 8-cell onwards CDX2
t the blastocyst stage. (b) shows a single optical section through the
CDX2 immunostaining was detected in the TE with some residual
ks chromatin. Confocal sections were taken every 3 μm.
Figure 9 CDX2 displays nuclear localisation and labels metaphase chromosomes. (a) presents 2 consecutive optical sections through an
early bovine embryo double labelled for CDX2 and for histone lysine methylation H3K9me3. White arrow heads point to a typical
heterochromatin distribution pattern at the periphery of the interphase nucleus. Green arrow heads indicate CDX2 and H3K9me3 colocalisation.
Dashed circle in (a) highlights the metaphase plate. CDX2 signal overlays the chromosomes and colocalises with condensed, transcriptionally
silent chromatin as indicated by H3K9me3 immunostaining enlarged in the right panel. (b) presents an optical scan through middle of late
morula embryo (beginnings of cavity formation may be visible in top section of the embryo). CDX2 displays nuclear localisation and also labels
the metaphase chromosomes (marked by the dashed white circle, the area is enlarged in the boxed panel). (c) HBl (9dpi) immunostained for
CDX2. Dashed white circle highlights the metaphase plate where, the encircled area is enlarged in the boxed panel where the CDX2 signal
colocalisation with metaphase chromosomes is visible. DAPI marks chromatin. Confocal sections were taken every 3 μm.
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blastocysts. Therefore, the aim of our study was to resolve
the doubts arising from the analysis of already published
material on bovine lineage specification and to identify
the time point at which bovine ICM/TE lineage segregation
begins.The first developmental stage investigated was the 5-cell
stage which precedes the critical time in bovine develop-
ment – the transition from maternal to embryonic control
of development (MET) [58]. In the mouse MET is initiated
at the 2-cell stage. In cattle this process is gradual and
may be divided into three stages: (1) early gene activation
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activation at 2–5 cell stage accompanied by de novo
RNA synthesis [60-64] and (3) a major burst of gene
activation at the 8–16 cell stage. At the 8–16 cell stage we
have detected transcripts for the three canonical lineage
markers: OCT4, NANOG and CDX2. The corresponding
protein products were noted only for OCT4 and CDX2.
Studies on in vitro derived bovine embryos revealed a
sudden drop in the mRNA level around the 4-cell stage,
reaching a minimal value at 8–16 cells [65]. The results
obtained here indicate that between the time of EGA and
morula formation NANOG appear de novo as a product of
the embryonic genome, as NANOG protein was detected
from the morula stage onwards. In support of this assump-
tion NANOG transcripts and protein were not detected in
bovine germinal vesicle (GV) and in vitro matured oocytes
[55]. Porcine embryos, which share similar morphological
stages of preimplantation development with bovine em-
bryos, display similar mRNA expression patterns for OCT4
and CDX2 genes. After EGA, a sudden increase in the
mRNA abundance was noted for bovine OCT4 and
NANOG and for porcine OCT4 and CDX2 [56,66].
OCT4 transcript expression appears highly conserved
between mouse and bovine blastocysts. In both species
OCT4 transcription begins one to two cell cycles after
zygotic genome activation and is followed by a sharp
increase in the mRNA abundance subsequent to compac-
tion. OCT4 mRNA was ubiquitously present in all cells of
morula stage, however 7dpi (early bovine blastocyst stage)
it become restricted to the ICM as indicated by in situ
hybridisation [49].
Our studies indicate that early in development (5-cell
stage) CDX2 and OCT4 proteins are both located in the
cytoplasm of bovine blastomeres, however with slightly
different distribution patterns. CDX2 was evenly distrib-
uted within the cytoplasm and absent in the nuclei. This
is different from the expression pattern described in the
mouse, where Cdx2 expression becomes detectable from
8–16 cell stage onwards with only nuclear localisation [15].
It indicates that CDX2 expression in cattle precedes the
EGA and the stage at which a clear distinction between
the inner and the outer cells becomes evident. OCT4
localised at the apical surface of the blastomeres. Asym-
metric distribution of CDX2 transcripts has been shown
in the cytoplasm of early mouse embryos (4–8 cell) [66].
Cytoplasmic localisation implies synthesis and accumula-
tion of proteins, thus prior to the EGA bovine embryos
may be actively synthesising transcription factors required
for lineage specification, what coincides with the gradual
process of bovine genome activation. As indicated by our
studies at the time of bovine genome activation CDX2 and
OCT4 specifically allocate in the nuclei. Cell fate decisions
are governed by active interactions between all of the core
pluripotency factors, as cells co-express them until a certainthreshold is achieved. In the mouse until the late blastocyst
stage (3.5/4.0-dpi) CDX2, NANOG and OCT4 proteins
exhibit salt and pepper distribution patterns ([41], rev [67]).
In the bovine embryo this distribution has been observed,
as early blastocysts (7dpi) contained on average 39.5%
double positive cells (NANOG and GATA6) [57]. At 8dpi
only 6.7% of all NANOG positive cells within the ICM
were also positive for GATA6 [57].
As development progresses bovine ICM/TE lineage
specification becomes more evident. We have observed
that in the early blastocyst (7dpi) at the time of cavita-
tion and spatial separation of the two lineages OCT4
and NANOG occupy the nuclei of the ICM cells. In
the neighbouring TE cells however, the proteins have
colocalised in the cytoplasm and were absent from the
nucleus. This may be the first indication at how functional
differences correlate with the cell’s position. In order to be
active as transcription factors OCT4 and NANOG need
to enter the nucleus, therefore at this stage the proteins
may be subjected to an active transportation. OCT4 “rings”
observed at the nuclear periphery of the ICM cells may be
reflecting this activity. At mid blastocyst stage (8dpi)
NANOG and OCT4 colocalised, which is in agreement
with studies indicating mutual functional stimulation be-
tween these factors [68-71]. At the same developmental
stage CDX2 segregation to the TE also became apparent,
however some ICM cells still expressed both CDX2 and
OCT4. Similarly as has been described in early mouse
blastocysts [20], a residual CDX2 signal was detected in
the ICM of bovine blastocysts, but in general the ICM
was free of CDX2 immunostaining. In late blastocysts
we observed OCT4 labelled cells only within the ICM.
This has also been observed by Berg et al. [32], who
noted measureable amounts of OCT4 in the TE of early
bovine blastocysts (7dpi) and none by day 11. The authors
indicated that in cattle CDX2 does not repress OCT4
expression, since bovine OCT4 locus does not contain the
cis-acting regulatory region necessary for extinguishing
transcription in the TE. Nevertheless CDX2 is required for
TE maintenance at later developmental stages. This is also
true for other species: humans, primates, pigs, horses and
rabbits [56,72-75]. Finally, in blastocysts 9dpi we have
observed further cellular specification as we have noted
cells expressing only NANOG and cells expressing both
NANOG and OCT4. Our comparison of relative transcript
abundance between bovine ICM and TE corresponds
to the protein distribution patterns described here. At
the mRNA level we have observed a lineage specific
upregulation of OCT4, NANOG and FN1 in the ICM and
KRT-18 in the TE. Notably, the majority of the ICM sam-
ples (9/12) lacked the specific transcript for CDX2. These
results present a similar CDX2 mRNA expression pattern
as has been described for mouse, human and also recently
primate embryos [73]. Consequently, within the set of the
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Such segregation of key factors responsible for epiblast de-
velopment may be a prerequisite to further differentiation
processes that take place in the bovine embryo between
the HBl stage and implantation (around 20dpi). In the
mouse, the epiblast formation is defined by two segregation
events that depend on the consecutive expression of Oct4
and Nanog. It is therefore plausible that our observations
capture the time point at which these processes are initiated
in bovine development and indicate that at the molecular
level the machinery of cell lineage differentiation is active.
Interestingly factors considered as potential bovine blas-
tocyst formation markers FN-1 and KRT-18 [76,77] also
showed lineage specific differences. FN-1 is a glycoprotein
component of the extracellular matrix involved in various
processes related to early development such as fertilisation,
gastrulation and implantation. We have noted FN-1 and
KRT-18 transcripts already at the morula stage. FN-1
may be an important factor in the process of compac-
tion and blastocyst formation, as its major biological
functions are cell adhesion, cytoskeleton organisation and
cell migration. Interactions between all of these processes
are essential for early development and cell lineage segre-
gation. Differentiative cell divisions at the morula stage
create spatial grounds for the allocation of smaller inner
cells to the ICM and larger polarised outer cells to the
TE. KRT-18, a cytoskeletal protein, may be seen as a TE
specific factor, since targeted deletion of KRT-18 in mouse
embryos resulted in trophoblast fragility and early embry-
onic lethality [78]. We have detected a significant up-
regulation of KRT-18 gene in bovine TE as compared to
the ICM, what makes it an interesting candidate for further
investigations of bovine TE lineage formation. Other
factors KLF4, c-MYC, REX1 and GATA6 did not exhibit
lineage specific differences at the mRNA level. Studies
showed that GATA6 mRNA was detected in both PrE
and TE outgrowths of bovine blastocysts 8dpi [79]. Fur-
thermore KLF4 and c-MYC may not be essential to main-
tain bovine ICM, since it was indicated that the expression
of these two factors alongside OCT4 and SOX2, was not
sufficient to induce pluripotency in bovine adult fibroblasts
[80]. This may be explained by species specific differences
between mouse and cattle as unlike in the mouse, bovine
TE is formed from the cells surrounding the blastocyst
cavity, not from the ones which cover the ICM [50].
Corresponding to our results Rex1 mRNA was detected
in mouse ICM and in polar trophoblast of 4.5dpi blasto-
cyst. Later in mouse development Rex1 was found in
trophoblast-derived tissues (ectoplacental cone and extra-
embryonic ectoderm) of the egg cylinder [81]. Thus Rex1
is regarded as the main factor enabling mouse ESC and
epiblast stem cells (EpiSC) to be distinguished.
On a close examination of 8-cell, morula and blastocyst
stage embryos we have made a very interesting observation,as in a small proportion of embryos (about 2%) a positive
signal for the CDX2 overlapped with the mitotic chromo-
somes. Moreover, the areas of higher CDX2 intensity in
some regions colocalised with DNA labelling fluorochrome
(DAPI), which to a certain degree may indicate the differ-
ences in chromatin compaction. Because DAPI preferably
binds to the AT-rich heterochromatin regions [47] we have
used an antibody directed against histone H3 lysine 9
tri-methylation (H3K9me3), which is believed to be associ-
ated with the formation of polyploid trophoblast giant
cells from diploid trophoblast precursors [82] and together
with H3K27 methylation in lysine is correlated with
transcriptional repression [83]. In a study of the dynamics
of constitutive heterochromatin in bovine nuclear transfer
and in vitro produced embryos, H3K9me3 colocalised
with heterochromatin protein CBX1 (HP1) in 95% of the
nuclei and the signal was displayed in patches [84]. This
expression pattern was similar to our observations. Double
immunofluorescent labelling of 8-cell bovine embryos
for CDX2 and H3K9me3 revealed a possible colocalisation
of these factors in the interphase nuclei and at the specific
regions on the metaphase chromosomes. CDX2 and
H3K9me3 colocalisation concurs with the above sugges-
tions, especially since chromatin immunoprecipitation ex-
periments have detected H3K9me3 at numerous promoters
in trophoblast tissues. Increased H3K9me3 levels were
detected at Cdx2, Eomes and Esrrb promoter regions of
ectoplacental cones as compared to extra embryonic
endoderm. Thus H3K9me3 may be regarded as a repres-
sive histone marker in early trophoblast development. At
this stage data interpretation must be done with much
caution, however the phenomenon of mitotic retention of
cell fate determining transcription factors, as an epigenetic
mechanism regulating gene expression has already been
described [85]. At the time of EGA major transcriptional
activation takes place. This process directly links chroma-
tin changes, protein allocation and nuclear reorganisation.
Mitotic remodelling of cellular and nuclear architecture
includes dynamic redistribution of transcription factors
(OCT4, ETS1, B-Myb, SP) and degradation of key regula-
tory proteins (such as cyclins) [86]. After mitosis, the struc-
tural and functional identity of cell’s regulatory machinery
must be re-established. Enzymatically and chemically
sensitive sites on mitotic chromosomes mark active genes.
It is therefore plausible that some regulatory complexes
remain bound to the condensed chromatin for rapid re-
activation after cell division. For example a hematopoietic
cell fate determining factor Runx2 remains associated with
chromosomes during mitosis through sequence specific
chromosome binding [85]. When transcription terminates
at the time of chromosome condensation, Runx2 selectively
occupies target gene promoters. This allows speculation on
possible parallels with the observed CDX2 localisation
pattern. There is an intriguing possibility that CDX2
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cell fate through the process of mitotic retention. This is a
new finding that is currently a subject of our detailed
investigations.
Conclusions
We have observed that the protein distribution patterns
in bovine blastocysts 8-9dpi mostly resemble the mouse
model. The differences were noted at earlier developmental
stages. In 5 cell embryos CDX2 and OCT4 proteins located
in the cytoplasm of bovine blastomeres, but presented
slightly different distribution patterns. CDX2 was evenly
distributed within the cytoplasm and absent in the nuclei.
OCT4 localised at the apical surface of the blastomeres.
We have noted changes in sub-cellular and sub-nuclear
distribution of pluripotency related factors during the
subsequent stages of development. From 8–16 cell stage
both proteins displayed a nuclear localisation, but from
the morula stage the specific lineage segregation became
visible as OCT4 became ICM specific and CDX2 located
in the TE layer. NANOG was initially detected in the cyto-
plasm of certain cells of the morula stage embryos and
became ICM specific at 8dpi. Finally it may be speculated
that CDX2 possibly occupies transcriptionally silent regions
of the early bovine nuclei as it was found to colocalise
with about 2% of the observed metaphase plates.
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